Pulmonary Fibrosis Support Group

Diffuse parenchymal lung disease (DPLD), also known as interstitial lung disease, refers to a group of lung diseases, affecting the alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. The term DPLD is used to distinguish these diseases from obstructive airways diseases. Most types of DPLD involve fibrosis, but this is not essential; indeed fibrosis is often a later feature.

0 Online

BIBF 1120 IPF drug

For those not in the know, BIBF 1120 has been showing some positive results for PF patients. It does not stop or reverse the disease, but it does help patients with quality of life.

http://www.prnewswire.com/news-releases/new-study-published-in-new-england-journal-of-medicine-shows-investigational-bibf-1120-demonstrated-positive-trend-in-reducing-lung-function-loss-in-idiopathic-pulmonary-fibrosis-130304818.html

clinical trials for phase 3 are ongoing now....